COMPLERA
COMPLERA
Approved
DIN Number
02374129
Drug Class
Human
Market Date
Oct 20, 2011
Company
HC
gilead sciences canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02374129
AIG Number0353001001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AR08 EMTRICITABINE, TENOFOVIR DISOPROXIL AND RILPIVIRINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.08.20
Health Canada Classification
ACTIVE INGREDIENTS (3)
EMTRICITABINEActive
Strength: 200 MG
Monograph: EMTRICITABINE
RILPIVIRINE (RILPIVIRINE HYDROCHLORIDE)Active
Strength: 25 MG
Monograph: RILPIVIRINE (RILPIVIRINE HYDROCHLORIDE)
TENOFOVIR DISOPROXIL FUMARATEActive
Strength: 300 MG
Monograph: TENOFOVIR DISOPROXIL FUMARATE